HHS Header
Printer FriendlyPrinter Friendly

ORI Updates

Feb 19

ORI is seeking to fund projects that foster innovative approaches to empirical research on societal, organizational, group, and individual factors that affect, both positively and negatively, integrity in research. The research will be reviewed and funded in a two-phase process. For this first phase, ORI is seeking small-scale, developmental research projects. ORI anticipates that Phase I awards will have a ceiling of up to $75,000 for a period of 12 months 

Feb 12

The Office of Research Integrity (ORI) seeks to support conferences to develop multi-disciplinary networks to build upon existing evidence-based research and stimulate innovative approaches to preventing research misconduct and promoting research integrity. ORI is especially interested in supporting conferences that lead to extramural grant applications on research on research integrity and peer-reviewed publications.

Jan 22

Dong Xiao, Ph.D. admitted that he had “intentionally fabricated data contained in a paper entitled ‘Guggulsterone inhibits prostate cancer growth via inactivation of Akt regulated by ATP citrate signaling."

Jan 20

ORI found that Dr. Bin Kang engaged in research misconduct by falsifying data that were included in the following two publications and two grant applications.

Dec 19

ORI found that Dr. H. Rosie Xing engaged in research misconduct by falsifying images in research supported by National Cancer Institute (NCI), National Institutes of Health (NIH).

  • RSS
  • RSS
  • Twitter
  • Listservs